176 related articles for article (PubMed ID: 33087770)
1. Potent inhibition of tumour cell proliferation and immunoregulatory function by mitochondria-targeted atovaquone.
Cheng G; Hardy M; Topchyan P; Zander R; Volberding P; Cui W; Kalyanaraman B
Sci Rep; 2020 Oct; 10(1):17872. PubMed ID: 33087770
[TBL] [Abstract][Full Text] [Related]
2. Combining PEGylated mito-atovaquone with MCT and Krebs cycle redox inhibitors as a potential strategy to abrogate tumor cell proliferation.
Cheng G; Hardy M; You M; Kalyanaraman B
Sci Rep; 2022 Mar; 12(1):5143. PubMed ID: 35332210
[TBL] [Abstract][Full Text] [Related]
3. Targeting mitochondria by anthelmintic drug atovaquone sensitizes renal cell carcinoma to chemotherapy and immunotherapy.
Chen D; Sun X; Zhang X; Cao J
J Biochem Mol Toxicol; 2018 Sep; 32(9):e22195. PubMed ID: 30004155
[TBL] [Abstract][Full Text] [Related]
4. Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells.
Fiorillo M; Lamb R; Tanowitz HB; Mutti L; Krstic-Demonacos M; Cappello AR; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2016 Jun; 7(23):34084-99. PubMed ID: 27136895
[TBL] [Abstract][Full Text] [Related]
5. OXPHOS-targeting drugs in oncology: new perspectives.
Kalyanaraman B; Cheng G; Hardy M; You M
Expert Opin Ther Targets; 2023; 27(10):939-952. PubMed ID: 37736880
[TBL] [Abstract][Full Text] [Related]
6. Targeting mitochondrial respiration as a therapeutic strategy for cervical cancer.
Tian S; Chen H; Tan W
Biochem Biophys Res Commun; 2018 May; 499(4):1019-1024. PubMed ID: 29630860
[TBL] [Abstract][Full Text] [Related]
7. Atovaquone at clinically relevant concentration overcomes chemoresistance in ovarian cancer via inhibiting mitochondrial respiration.
Guo Y; Hu B; Fu B; Zhu H
Pathol Res Pract; 2021 Aug; 224():153529. PubMed ID: 34174549
[TBL] [Abstract][Full Text] [Related]
8. Dithiothreitol abrogates the effect of arsenic trioxide on normal rat liver mitochondria and human hepatocellular carcinoma cells.
Paul MK; Kumar R; Mukhopadhyay AK
Toxicol Appl Pharmacol; 2008 Jan; 226(2):140-52. PubMed ID: 18022205
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of mitochondrial respiration overcomes hepatocellular carcinoma chemoresistance.
Sun Y; Xu H; Chen X; Li X; Luo B
Biochem Biophys Res Commun; 2019 Jan; 508(2):626-632. PubMed ID: 30522865
[TBL] [Abstract][Full Text] [Related]
10. A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds.
Kalyanaraman B; Cheng G; Hardy M; Ouari O; Lopez M; Joseph J; Zielonka J; Dwinell MB
Redox Biol; 2018 Apr; 14():316-327. PubMed ID: 29017115
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide induces apoptosis in uveal melanoma cells through the mitochondrial pathway.
Chen MJ; Yang PY; Ye YZ; Hu DN; Chen MF
Am J Chin Med; 2010; 38(6):1131-42. PubMed ID: 21061466
[TBL] [Abstract][Full Text] [Related]
12. ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells.
Gu S; Chen C; Jiang X; Zhang Z
Chem Biol Interact; 2016 Feb; 245():100-9. PubMed ID: 26772155
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide-induced cytotoxicity in small cell lung cancer via altered redox homeostasis and mitochondrial integrity.
Zheng CY; Lam SK; Li YY; Ho JC
Int J Oncol; 2015 Mar; 46(3):1067-78. PubMed ID: 25572414
[TBL] [Abstract][Full Text] [Related]
14. A porphysome-based photodynamic O
Zheng R; Chen X; Zhao L; Yang N; Guan R; Chen A; Yu X; Cheng H; Wang C; Li S
Chem Commun (Camb); 2021 Apr; 57(34):4134-4137. PubMed ID: 33908446
[TBL] [Abstract][Full Text] [Related]
15. Prevention of Tumor Growth and Dissemination by In Situ Vaccination with Mitochondria-Targeted Atovaquone.
Huang M; Xiong D; Pan J; Zhang Q; Wang Y; Myers CR; Johnson BD; Hardy M; Kalyanaraman B; You M
Adv Sci (Weinh); 2022 Apr; 9(12):e2101267. PubMed ID: 35243806
[TBL] [Abstract][Full Text] [Related]
16. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
Li W; Wang M; Wang L; Ji S; Zhang J; Zhang C
Cell Biochem Biophys; 2014 Mar; 68(2):427-36. PubMed ID: 23975599
[TBL] [Abstract][Full Text] [Related]
17. A mitochondrial-metabolism-regulatable carrier-free nanodrug to amplify the sensitivity of photothermal therapy.
Du Q; Qin X; Zhang M; Zhao Z; Li Q; Ren X; Wang N; Luan Y
Chem Commun (Camb); 2021 Sep; 57(71):8993-8996. PubMed ID: 34486606
[TBL] [Abstract][Full Text] [Related]
18. Phloretin ameliorates arsenic trioxide induced mitochondrial dysfunction in H9c2 cardiomyoblasts mediated via alterations in membrane permeability and ETC complexes.
Vineetha VP; Soumya RS; Raghu KG
Eur J Pharmacol; 2015 May; 754():162-72. PubMed ID: 25746422
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284
[TBL] [Abstract][Full Text] [Related]
20. The anti-malarial atovaquone selectively increases chemosensitivity in retinoblastoma via mitochondrial dysfunction-dependent oxidative damage and Akt/AMPK/mTOR inhibition.
Ke F; Yu J; Chen W; Si X; Li X; Yang F; Liao Y; Zuo Z
Biochem Biophys Res Commun; 2018 Oct; 504(2):374-379. PubMed ID: 29902460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]